The development of Neolys Diagnostics tests is the result of a meeting between industry and radiobiology researchers from Lyon (INSERM unit).
First of all, our team has developed a reliable technology, based on the implementation of predictive tests, allowing the personalization of radiotherapy treatments.
We are responding to a need: to predict the radiosensitivity reactions after radiotherapy for each patient, taking into account individual specificities.
Our team is mainly composed of professional biology researchers, specialized in radiobiology.
PhD in radiobiology, Sandrine is also an industrial transfer and medical devices specialist. She supervises the R&D department of the company.
R&D Manager - Project Manager
PhD in radiobiology, Elise supervises the company’s research and development unit.
Phd in science specialising in chemistry and biology and a master’s degree in innovation management. Patrick is in charge of business development.
Mirlande takes part in R&D experiments and is specialized in performing radiosensitivity tests.